• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Color-Changing Nanoparticulate Transdermal Patches

Rinti Banerjee of IIT Bombay in India will develop skin patches for safer and more effective dosing of the antibiotic amoxicillin in children with pneumonia in developing countries. Amoxicillin is usually provided as a tablet or powder that requires multiple doses per day, which, along with the bitter taste, is off-putting for children. They will develop amoxicillin-enclosed lipid nanoparticles that mimic the outer surface of the skin, and optimize their size and ability to encapsulate the drug. These nanoparticles will be added to multilayered transdermal patches that allow the continued release of amoxicillin through the skin, and contain a dye that indicates when the patch needs changing. The patches will be first evaluated on pigs' skin, and in mice and rats.

More information about New Ways to Reduce Pneumonia Fatalities Through Timely, Effective Treatment of Children (Round 14)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.